Adhera Therapeutics, Inc. Contracts & Agreements

Assignment and Exchange Agreement (Filed With SEC on November 29, 2023)

Side Letter Agreement (Filed With SEC on November 29, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on June 29, 2023)

Form of Warrant (Filed With SEC on June 29, 2023)

Form of Securities Purchase Agreement (Filed With SEC on June 29, 2023)

Form of Security Agreement (Filed With SEC on June 29, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on May 5, 2023)

Form of Warrant (Filed With SEC on May 5, 2023)

Form of Securities Purchase Agreement (Filed With SEC on May 5, 2023)

Form of Security Agreement (Filed With SEC on May 5, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on May 4, 2023)

Form of Warrant (Filed With SEC on May 4, 2023)

Form of Securities Purchase Agreement (Filed With SEC on May 4, 2023)

Form of Security Agreement (Filed With SEC on May 4, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on March 8, 2023)

Form of Warrant (Filed With SEC on March 8, 2023)

Form of Securities Purchase Agreement (Filed With SEC on March 8, 2023)

Form of Security Agreement (Filed With SEC on March 8, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on February 23, 2023)

Form of Warrant (Filed With SEC on February 23, 2023)

Form of Securities Purchase Agreement (Filed With SEC on February 23, 2023)

Form of Security Agreement (Filed With SEC on February 23, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on January 26, 2023)

Form of Warrant (Filed With SEC on January 26, 2023)

Form of Securities Purchase Agreement (Filed With SEC on January 26, 2023)

Form of Security Agreement (Filed With SEC on January 26, 2023)

Employment Agreement dated June 29, 2022 between Adhera Therapeutics, Inc. and Zahed Subhan (Filed With SEC on August 15, 2022)

Second Addendum to the License Agreement (Filed With SEC on August 4, 2022)

Form of Securities Purchase Agreement dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Senior Secured Original Issue Discount Promissory Note dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Warrant dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Security Agreement dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Convertible Redeemable Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022 (Filed With SEC on April 15, 2022)

License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 (Filed With SEC on April 15, 2022)

Addendum to License Agreement Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 dated February 16, 2022 (Filed With SEC on April 15, 2022)

Form of Securities Purchase Agreement issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022 (Filed With SEC on April 15, 2022)

Form of 10% Convertible Redeemable Note (Filed With SEC on November 12, 2021)

Form of Warrant (Filed With SEC on November 12, 2021)

Form of Securities Purchase Agreement (Filed With SEC on November 12, 2021)

Form of Securities Purchase Agreement (Filed With SEC on October 13, 2021)

Form of 10% Convertible Redeemable Note (Filed With SEC on October 13, 2021)

Form of Warrant (Filed With SEC on October 13, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 24, 2021)

Form of Warrant (Filed With SEC on August 24, 2021)

Form of Securities Purchase Agreement (Filed With SEC on August 24, 2021)

Form of Convertible Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021 (Filed With SEC on August 23, 2021)

Form of Common Stock Purchase Warrants issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021 (Filed With SEC on August 23, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 18, 2021)

Form of Warrant (Filed With SEC on August 18, 2021)

License Agreement (Filed With SEC on August 4, 2021)

Form of Convertible Promissory Note (Filed With SEC on April 23, 2021)

Form of Warrant (Filed With SEC on April 23, 2021)

Form of Convertible Promissory Note (Filed With SEC on February 9, 2021)

Form of Warrant (Filed With SEC on February 9, 2021)

Form of Senior Secured Convertible Note (Filed With SEC on November 5, 2020)

Form of Warrant (Filed With SEC on November 5, 2020)

Consulting Agreement between Company and Andrew Kucharchuk (Filed With SEC on July 13, 2020)

Form of Convertible Promissory Note (Filed With SEC on June 30, 2020)

Security Agreement dated June 26, 2020 (Filed With SEC on June 30, 2020)

Description of Securities (Filed With SEC on April 14, 2020)

Form of Convertible Promissory Note (Filed With SEC on February 11, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on February 11, 2020)

Securities Purchase Agreement dated as of February 5, 2020 between Adhera Therapeutics, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on February 11, 2020)

Employment Agreement, dated as of October 29, 2019, by and between Adhera Therapeutics, Inc. and Rhonda Stanley (Filed With SEC on November 4, 2019)

Form of Subscription Agreement (Filed With SEC on August 7, 2019)

Form of Secured Promissory Note (Filed With SEC on July 3, 2019)

Security Agreement, dated as of June 28, 2019, among Adhera Therapeutics, Inc., IThenaPharma, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., the purchasers of secured... (Filed With SEC on July 3, 2019)

Form of Subscription Agreement used in connection with the offering of the Series F Convertible Preferred Stock of the Registrant (Filed With SEC on April 16, 2019)

2018 Long-Term Incentive Plan of the Registrant (Filed With SEC on April 16, 2019)

Employment Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Nancy R. Phelan (Filed With SEC on April 5, 2019)

Settlement Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Robert R. Moscato, Jr (Filed With SEC on April 5, 2019)

Omnibus Settlement Agreement, dated as of September 28, 2018, by and among Marina Biotech, Inc., Vuong Trieu, Ph.D., Autotelic Inc., Autotelic LLC, Autotelic BIO, Oncotelic, Inc.... (Filed With SEC on October 3, 2018)

Employment Agreement, dated as of September 24, 2018, by and between Marina Biotech, Inc. and R. Eric Teague (Filed With SEC on September 24, 2018)

Form of Common Stock Purchase Warrant (Filed With SEC on July 16, 2018)

Employment Agreement, dated June 18, 2018, by and between Marina Biotech, Inc. and Robert C. Moscato, Jr (Filed With SEC on June 20, 2018)

Placement Agency Agreement, dated February 8, 2018, by and between Marina Biotech, Inc. and Maxim Merchant Capital, a division of Maxim Group LLC (Filed With SEC on May 18, 2018)

Form of Subscription Agreement (Filed With SEC on May 18, 2018)

Form of Warrant (Filed With SEC on April 19, 2018)

Amendment to Convertible Promissory Note, dated December 22, 2017, by and between Marina Biotech, Inc. and River Charitable Remainder Unit Trust, FBO Isaac Blech, July 20, 2987,... (Filed With SEC on December 29, 2017)

Form of Secured Convertible Promissory Note (Filed With SEC on November 24, 2017)

Stock Option Agreement dated as of November 22, 2017 by and between Marina Biotech, Inc. and Isaac Blech (Filed With SEC on November 24, 2017)

Note Purchase Agreement dated as of November 22, 2017 by and between Marina Biotech, Inc. and River Charitable Remainder Unit Trust, FBO Isaac Blech, July 20, 2987, Isaac Blech... (Filed With SEC on November 24, 2017)

Security Agreement, dated as of November 22, 2017, among Marina Biotech, Inc., IThenaPharma Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc. and River Charitable... (Filed With SEC on November 24, 2017)

Intellectual Property Security Agreement, dated as of November 22, 2017, by Marina Biotech, Inc., IThenaPharma Inc., Cequent Pharmaceuticals, Inc. and MDRNA Research, Inc. in... (Filed With SEC on November 24, 2017)

License Agreement dated July 17, 2017 between Marina Biotech, Inc. and Oncotelic, Inc (Filed With SEC on November 13, 2017)

Amendment Agreement, dated August 3, 2017, by and among Marina Biotech, Inc. and the lenders signatory thereto (Filed With SEC on November 13, 2017)

Employment Offer Letter dated October 12, 2017 between Marina Biotech, Inc. and Peter D. Weinstein, Ph.D., J.D (Filed With SEC on October 18, 2017)

Employment Offer Letter dated October 2, 2017 between Marina Biotech, Inc. and Amit Shah (Filed With SEC on October 6, 2017)

Intellectual Property Purchase Agreement dated as of September 8, 2017 by and between Marina Biotech, Inc. and Novosom Verwaltungsgesellschaft mbH (Filed With SEC on September 14, 2017)

ASSETPURCHASE AGREEMENT (Filed With SEC on July 25, 2017)

MARINABIOTECH, INC. 17870Castleton Street, Suite 250 Cityof Industry, California 91748 (Filed With SEC on July 5, 2017)

MARINABIOTECH, INC. 17870Castleton Street, Suite 250 Cityof Industry, CA 91748 (Filed With SEC on June 28, 2017)

MARINABIOTECH, INC. 17870Castleton Street, Suite 250 Cityof Industry, California 91748 (Filed With SEC on June 28, 2017)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on June 7, 2017)

ASSETPURCHASE AGREEMENT Datedas of June 5, 2017 Among SYMPLMEDPHARMACEUTICALS LLC, and MARINABIOTECH, INC. (Filed With SEC on June 7, 2017)

NOTEPURCHASE AGREEMENT (Filed With SEC on June 7, 2017)

LICENSEAGREEMENT (Filed With SEC on May 15, 2017)

DEMANDPROMISSORY NOTE (Filed With SEC on April 6, 2017)

AutotelicInc. 940South Coast Drive, Suite 100 CostaMesa, CA 92626 (Filed With SEC on April 6, 2017)

MARINABIOTECH, INC. 17870Castleton Street, Suite 250 Cityof Industry, CA 91748 (Filed With SEC on February 14, 2017)

STOCKPURCHASE AGREEMENT (Filed With SEC on February 9, 2017)

MARINABIOTECH, INC. 17870Castleton Street, Suite 250 Cityof Industry, CA 91748 (Filed With SEC on February 3, 2017)

AGREEMENTAND PLAN OF MERGER (Filed With SEC on November 18, 2016)

DEMANDPROMISSORY NOTE (Filed With SEC on November 18, 2016)

MASTERSERVICES AGREEMENT (Filed With SEC on November 18, 2016)

VuongTrieu 4003Jim Bowie AgouraHills, CA 91301 (Filed With SEC on November 18, 2016)

PROMISSORYNOTE (Filed With SEC on June 22, 2016)

NOTE PURCHASEAGREEMENT (Filed With SEC on June 22, 2016)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on August 10, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 10, 2015)

AMENDMENT No. 2 to LICENSE AGREEMENT (Filed With SEC on May 14, 2015)

MARINA BIOTECH, INC. [______] Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase Up To [___] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 7, 2015)

MARINABIOTECH, Inc. Warrant To Purchase Common Stock (Filed With SEC on April 7, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on September 19, 2014)

MARINA BIOTECH, INC. 2014 LONG-TERM INCENTIVE PLAN * * * * * (Filed With SEC on September 19, 2014)

SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on July 22, 2014)

CONSULTING AGREEMENT (Filed With SEC on July 22, 2014)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on March 11, 2014)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on March 11, 2014)

Convertible Preferred Financing (Filed With SEC on February 24, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 14, 2013)

FIFTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on February 12, 2013)

COMMON STOCK PURCHASE WARRANT marinabiotech, inc. (Filed With SEC on February 5, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 5, 2013)

LicenseAgreement ByAnd Between Novartisinstitutes for biomedical research, inc. And MarinaBiotech, Inc. (Filed With SEC on December 5, 2012)

INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on November 14, 2012)

AMENDMENT TO SECURITIES PURCHASEAGREEMENT, WARRANT TO PURCHASE COMMON STOCK, AND SECURED PROMISSORY NOTE (Filed With SEC on October 10, 2012)

AMENDMENT No. 2 TO SECURITIES PURCHASEAGREEMENT (Filed With SEC on October 10, 2012)

FIRST AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on October 10, 2012)

SECOND AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on October 10, 2012)

AMENDMENT NO. 1TO RESEARCH AND LICENSE AGREEMENT (Filed With SEC on October 10, 2012)

AMENDMENT NO. 2 TO RESEARCH AND LICENSEAGREEMENT (Filed With SEC on October 10, 2012)

AMENDMENT NO. 3 TO RESEARCH AND LICENSEAGREEMENT (Filed With SEC on October 10, 2012)

AMENDMENT NO. 4 TO RESEARCH AND LICENSEAGREEMENT (Filed With SEC on October 10, 2012)

FOURTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on October 10, 2012)

LEASE TERMINATION AGREEMENT (Filed With SEC on October 10, 2012)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on August 8, 2012)

THIRD AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT and SECURED PROMISSORY NOTES (Filed With SEC on August 8, 2012)

James M. Karis Chairman of the Board Marina Biotech, Inc. August 2, 2012 (Filed With SEC on August 8, 2012)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 26, 2012)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on March 20, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 20, 2012)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on March 20, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 19, 2012)

LICENSE AGREEMENT (Filed With SEC on February 22, 2012)

15% SECURED PROMISSORY NOTE THIS PROMISSORY NOTE MAY NOT BE TRANSFERREDOR ASSIGNED (Filed With SEC on February 13, 2012)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on February 13, 2012)

NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on February 13, 2012)

SECURITY AGREEMENT (Filed With SEC on February 13, 2012)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on February 13, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 23, 2011)

PURCHASE AGREEMENT (Filed With SEC on October 17, 2011)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 17, 2011)

LEASE TERMINATION AGREEMENT (Filed With SEC on October 4, 2011)

STOCK PURCHASE AGREEMENT (Filed With SEC on October 4, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2011)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2011)

MARINA BIOTECH, INC. 22,318,500 Units Each Unit Consisting of One Share of Common Stock and OneSeries A Warrant to Purchase One Share of Common Stock and 22,318,500 Series B... (Filed With SEC on May 17, 2011)

Void after 5:00 p.m. (New York time) on , 2011. (Filed With SEC on May 17, 2011)

RESEARCH AND LICENSE AGREEMENT (Filed With SEC on May 16, 2011)

MARINA BIOTECH, INC. Units Each Unit Consisting of One Share of Common Stock and OneSeries A Warrant to Purchase One Share of Common Stock and Series B Warrants, Each to Purchase... (Filed With SEC on May 10, 2011)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on May 10, 2011)

Void after 5:00 p.m. (New York time) on , 2011. (Filed With SEC on May 10, 2011)

MARINA BIOTECH, INC. Units Each Unit Consisting of One Share of Common Stock and of a Series A Warrant, Each to Purchase One Share of Common Stock and Series B Warrants, Each to... (Filed With SEC on May 2, 2011)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on May 2, 2011)

Void after 5:00 p.m. (New York time) on , 2011. (Filed With SEC on May 2, 2011)

EXHIBIT 1, SHEET 1 Building No. 600/700, One Kendall Square Cambridge, Massachusetts (the Building) (Filed With SEC on March 23, 2011)

FIRST AMENDMENT OF LEASE (Filed With SEC on March 23, 2011)

SECOND AMENDMENT OF LEASE (Filed With SEC on March 23, 2011)

THIRD AMENDMENT OF LEASE (Filed With SEC on March 23, 2011)

FOURTH AMENDMENT OF LEASE (Filed With SEC on March 23, 2011)

MARINA BIOTECH, INC. 6,375,000 Units Each Unit Consisting of One Share of Common Stock and 0.1746 of a Warrant, Each to Purchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 10, 2011)

[FORM OF WARRANT CERTIFICATE] EXERCISABLE ONLY IF COUNTERSIGNED BY THEWARRANT AGENT AS PROVIDED HEREIN. Warrant Certificate Evidencing Warrants to Purchase Common Stock, par value... (Filed With SEC on February 10, 2011)

WARRANT AGREEMENT (Filed With SEC on February 10, 2011)

FIFTH AMENDMENT TO LEASE (Filed With SEC on December 21, 2010)

STOCK PURCHASE AGREEMENT (Filed With SEC on December 21, 2010)

[FORM OF SUBSCRIPTION UNIT] MARINA BIOTECH, INC. SUBSCRIPTION INVESTMENT UNIT TO PURCHASECOMMON STOCK (Filed With SEC on November 5, 2010)

COMMON STOCK PURCHASE WARRANT MARINA BIOTECH, INC. (Filed With SEC on November 5, 2010)

AMENDMENT TOSECURITIES PURCHASE AGREEMENTS (Filed With SEC on November 5, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 5, 2010)

/s/ Jesper Wengel (Filed With SEC on August 12, 2010)

Ribotask ApS Promenadebyen 2, 8. sal, lejl. 4 DK-5000, Odense C Denmark June18, 2009 (Filed With SEC on August 12, 2010)

FIRST AMENDMENT DATED AS OF JANUARY 29, 2009 TO DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN AMYLIN PHARMACEUTICALS, INC. AND MDRNA, INC. (formerly Nastech Pharmaceutical... (Filed With SEC on August 12, 2010)

REGISTRATION RIGHTS AGREEMENT BY AND AMONG MDRNA, INC., AND THE INVESTORS SET FORTH ON SCHEDULE I HERETO Dated as of July 21, 2010 TABLE OF CONTENTS (Filed With SEC on July 23, 2010)

STOCKHOLDERS AGREEMENT (Filed With SEC on July 23, 2010)

AGREEMENT AND PLAN OF MERGER DATED AS OF MARCH 31,2010 BY AND AMONG MDRNA, INC., CALAIS ACQUISITION CORP., (Filed With SEC on April 6, 2010)

PROMISSORY NOTE (Filed With SEC on April 6, 2010)

COMMON STOCK PURCHASE WARRANT MDRNA, INC. (Filed With SEC on April 6, 2010)

AMENDMENT NO. 3 TO RIGHTS AGREEMENT (Filed With SEC on April 6, 2010)

Lock-Up Agreement (Filed With SEC on April 6, 2010)

LOAN AGREEMENT MDRNA, INC. 3830 Monte Villa Parkway Bothell, Washington 98021 (Filed With SEC on April 6, 2010)

SECURITY AGREEMENT (ALL ASSETS) (Filed With SEC on April 6, 2010)

SECURITY AGREEMENT (PATENTS) (Filed With SEC on April 6, 2010)

GUARANTY AGREEMENT (Filed With SEC on April 6, 2010)

MDRNA, INC. WAIVER AGREEMENT (Filed With SEC on April 6, 2010)

DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on March 23, 2010)

AMENDMENT NO. 2 TO RIGHTS AGREEMENT (Filed With SEC on March 5, 2010)

COMMON STOCK PURCHASE WARRANT MDRNA, INC. (Filed With SEC on January 14, 2010)

5,385,557 Shares Warrants to Purchase 3,500,612Shares MDRNA, INC. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on January 14, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 14, 2010)

FORM OF 12% SECURED PROMISSORY NOTE THISPROMISSORY NOTE MAY NOT BE TRANSFERRED OR ASSIGNED (Filed With SEC on December 24, 2009)

COMMON STOCK PURCHASE WARRANT MDRNA, INC. (Filed With SEC on December 24, 2009)

NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on December 24, 2009)

AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 30, 2009)

AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT MDRNA, INC. (Filed With SEC on July 30, 2009)

FOURTH AMENDMENT TO LEASE (Filed With SEC on July 30, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on July 14, 2009)

MDRNA, INC. 3830 Monte Villa Parkway Bothell, Washington 98021 (Filed With SEC on July 14, 2009)

5,250,000 Shares Warrants to Purchase 5,250,000 Shares (Filed With SEC on June 11, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 11, 2009)

COMMON STOCK PURCHASE WARRANT MDRNA, INC. (Filed With SEC on June 11, 2009)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2009)

NON-EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on May 15, 2009)

By And Between Novartis Institutes for BioMedical Research, Inc. And MDRNA, Inc. (Filed With SEC on May 15, 2009)

AMENDMENT, ACKNOWLEDGMENT AND MUTUAL RELEASE (Filed With SEC on March 23, 2009)

THIRD AMENDMENT TO LEASE (Filed With SEC on March 10, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 10, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on October 30, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on June 13, 2008)

MembersNASD & SIPC 405 Lexington Ave.New York, NY 10174 Tel ###-###-#### ###-###-#### fax ###-###-#### www.maximgrp.com New York, NY Long Island, NY Chicago. IL Red Bank, NJ... (Filed With SEC on April 30, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 30, 2008)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on April 30, 2008)

ESCROW AGREEMENT (Filed With SEC on April 30, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on March 10, 2008)

NASTECH PHARMACEUTICAL COMPANY INC. AMENDMENTS TO CERTAIN GRANT AGREEMENTS (Filed With SEC on March 10, 2008)

1/3 Of the shares subject to the Option shall be vested on 1/3 Of the shares subject to the Option shall be vested on 1/3 Of the shares subject to the Option shall be vested on (Filed With SEC on February 19, 2008)

Nastech Pharmaceutical Company Inc. 2004 Stock Incentive Plan Restricted Stock Grant Agreement (Filed With SEC on February 19, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on December 20, 2007)

In thousands, except share and per share data (Filed With SEC on May 7, 2007)

our ability to obtain additional funding (Filed With SEC on March 7, 2007)

Dr. Steven C. Quay (Filed With SEC on February 12, 2007)

EX-1.1: UNDERWRITING AGREEMENT (Filed With SEC on January 19, 2007)

EX-4.1: AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on January 19, 2007)

Current assets (Filed With SEC on November 1, 2006)

Current assets (Filed With SEC on August 2, 2006)

EX-10.1: AGREEMENT (Filed With SEC on July 26, 2006)

EX-10.1: LEASE (Filed With SEC on July 26, 2006)

our ability to obtain additional funding (Filed With SEC on March 15, 2006)

Lease between Ditty Properties Limited Partnership Landlord and Nastech Pharmaceutical Company Inc. Tenant dated March 1, 2006 (Filed With SEC on March 7, 2006)

EX-10.1: PRODUCT DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on February 2, 2006)

entered into a restricted stock grant agreement, effective as of January 1, 2006, with Mr. Ranker, pursuant to which he was issued 20,133 shares of restricted common stock of the... (Filed With SEC on January 5, 2006)

Current assets (Filed With SEC on November 2, 2005)

EX-10.1: AGREEMENT (Filed With SEC on October 18, 2005)

EX-10.1: AGREEMENT, RELEASE AND WAIVER (Filed With SEC on September 8, 2005)

UNDERWRITING AGREEMENT (Filed With SEC on August 30, 2005)

Current assets (Filed With SEC on August 1, 2005)

EX-10.1: RESTRICTED STOCK GRANT AGREEMENT (Filed With SEC on July 25, 2005)

EX-10.2: INCENTIVE STOCK OPTION GRANT AGREEMENT (Filed With SEC on July 25, 2005)

EX-10.3: NON-QUALIFIED STOCK OPTION GRANT AGREEMENT (Filed With SEC on July 25, 2005)

EX-10.4: AMENDMENT NO. 1 TO 2004 STOCK INCENTIVE PLAN (Filed With SEC on July 25, 2005)

Exhibit No (Filed With SEC on June 9, 2005)

Current assets (Filed With SEC on May 9, 2005)

our ability to obtain additional funding (Filed With SEC on March 8, 2005)

Exhibit No (Filed With SEC on January 27, 2005)

Current assets (Filed With SEC on October 27, 2004)

EXCLUSIVE DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT (Filed With SEC on September 30, 2004)

SUPPLY AGREEMENT (Filed With SEC on September 30, 2004)

EXECUTIVE OFFICERS OF THE REGISTRANT (Filed With SEC on March 15, 2004)

ITEM 1 FINANCIAL STATEMENTS (Unaudited) (Filed With SEC on August 14, 2003)

Executive officers of the Registrant (Filed With SEC on March 28, 2003)

Divestiture Agreement dated as of January 24, 2003 between the registrant and Pharmacia & Upjohn Company (Filed With SEC on February 21, 2003)

ITEM 1 FINANCIAL STATEMENTS (Filed With SEC on November 14, 2002)

Asset Purchase Agreement dated as (Filed With SEC on October 15, 2002)

Asset Purchase Agreement dated as of September 30, 2002, between the registrant and Schwarz Pharma, Inc (Filed With SEC on October 15, 2002)

ITEM 1 FINANCIAL STATEMENTS (Filed With SEC on August 14, 2002)

INVESTMENT AGREEMENT dated as of February 1, 2002 by and between PHARMACIA & UPJOHN COMPANY a Delaware corporation and NASTECH PHARMACEUTICAL COMPANY, INC., a Delaware corporation... (Filed With SEC on February 20, 2002)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 20, 2002)

COLLABORATION AND LICENSE AGREEMENT By and Between PHARMACIA & UPJOHN COMPANY And NASTECH PHARMACEUTICAL COMPANY, INC. TABLE OF CONTENTS (Filed With SEC on February 20, 2002)

SUPPLY AGREEMENT (Filed With SEC on February 20, 2002)

Category

Industry

Companies

Contracts

Adhera Therapeutics, Inc. Contracts & Agreements